Iron limitation is one major constraint of microbial life, and a plethora of microbes use siderophores for high affinity iron acquisition. Since specific enzymes for reductive iron release in Gram-positives are not known, we searched Firmicutes genomes and found a novel association pattern of putative ferric siderophore reductases (FSRs) and uptake genes. The reductase from the schizokinen-producing alkaliphile Bacillus halodurans was found to cluster with a ferric citrate-hydroxamate uptake system and to catalyze iron release efficiently from Fe Siderophore-dependent iron acquisition is an essential metabolic feature employed by a vast number of bacteria, fungi, plants and even higher eukaryotes (1) (2) (3) (4) . Key steps of typical siderophore pathways include siderophore synthesis, secretion, and uptake of siderophore-bound iron which is coupled to its intracellular or extracellular release. Within siderophore pathways, iron release processes are still widely uncharacterized. Generally, two enzymatic strategies are known for direct release of ferric siderophore complexes, which are hydrolysis of the siderophore backbone or reduction of the complexed ferric iron species, thus representing either scaffoldor metal-targeted release mechanism (5-7), which may not necessarily be mutually exclusive. Iron release outside the cytosol including compartments such as the bacterial periplasm or eukaryotic vacuoles may further be coupled to protonation of ferric siderophore complexes (8) (9) .
Hydrolytic release of iron is restricted to a small number of siderophores possessing bonds that can be efficiently attacked by water. Usually, these are ester bonds which are present in trilactone siderophores like enterobactin, bacillibactin, salmochelins, or triacetylfusarinine C. For those siderophores, several esterases have been described that partially or completely hydrolyze these intramolecular ester bridges (10) (11) (12) (13) (14) . The overwhelming majority of siderophores is assembled by amide bond formation and thus very robust against hydrolysis. Their ferric complexes are generally released by metal reduction and/or complex protonation. Reductive release in the extracellular environment has been described for the membrane-standing ferric reductases in yeast, especially Fre1p, Fre2p, Fre3p, and Fre4p (15) . They are similar to b-type cytochromes and belong to the flavocytochrome superfamily using FAD, NAD(P)H and heme cofactors for electron transfer during catalysis. Electron shuttling across the cytosolic membrane is suggested to be coupled with proton transfer resulting in extracellular acidification (16) , which may increase the redox potentials of the ferric complexes. Generally, the iron-chelate redox potentials greatly differ among the different classes of siderophores. Triscatecholates such as ferric enterobactin (Fe[III]-enterobactin) with iron binding affinities in the range of 10 49 M -1 possess standard redox potentials of their ferric complexes at E°[pH 7 .0] of -750 mV or lower (17) (18) . Redox potentials of hydroxamates such as ferrichrome or ferrioxamines, and citrate-hydroxamates such as ferric aerobactin (Fe[III]-aerobactin) are higher, but still in the negative range below an E°[pH 7 .0] of about -300 mV, while carboxylates such as ferric dicitrate (Fe[III]-dicitrate) are ranging above them at E°[pH 7 .0] of about 0 mV (6) . According to the physiological range of cellular redox compounds, many ferric siderophores can be potentially reduced by soluble redox cofactors, a mechanism which has mainly been decribed for cytosolic iron release in bacteria (6, 18) . In these cases, usually flavin reductases catalyze electron transfer from NAD(P)H towards different flavins such as FMN, FAD or riboflavin. These flavins may then be released from the enzyme as free reducing agents such as in Escherichia coli NAD(P)H:flavin oxidoreductase Fre and its homologs in Vibrio (19) , the sulfite reductase SiR (20) , and Magnetospirillum gryphiswaldense flavin reductase FeR (21) , or may stay enzyme-bound such as in E. coli flavohaemoglobin Hmp (22) , nitroreductase NfnB and ferredoxin-NADP + reductase Fpr (23) . In addition, extracellular FSRs dependent on NADH and flavins were described in several species including E. coli, Yersinia enterocolitica, Pseudomonas aeruginosa, and Listeria monocytogenes (24) . Generally, these FSRs act on a broad set of substrates including iron-loaded nonsiderophores such as cytochrome c or ferredoxin, and non-metals such as sulfite or nitro compounds, and hence are not specifically linked with iron assimilatory metabolism and regulation. Still, there are few examples of cytosolic FSRs showing a direct relation with iron metabolism as well as direct interaction with a defined set of ferric chelate substrates. One reductase that is suggested to fulfill these criteria is E. coli FhuF, which was shown to reduce several ferric hydroxamate complexes (25) (26) . FhuF contains a C-terminal iron-sulfur (Fe/S) cluster that likely permits electron transfer from the enzyme to its cognate substrates. While FhuF-type reductases are present in several enterobacterial species, further types of putative reductases with Cterminally conserved cysteine motif are distributed in other phyla including Firmicutes. Their reductases have not been characterized yet, and it has not been described that Gram-positive bacteria possess iron-regulated or substrate-defined FSRs. In this study, we describe for the first time a distinct FSR from a Gram-positive bacterium. The reductase was found to be iron-regulated and to possess a stably bound low-potential Fe/S cofactor. Its kinetic analysis revealed a redox-scaled substrate spectrum defined by both cluster midpoint potential and substrate affinity. Genetic analyses showed that its function is decisive for cellular iron metabolism and that it can be inhibited by redox-inert siderophores during iron deprivation. We thus present novel mechanistics insights into cytosolic iron release, which might have implications for antibiotic strategies.
EXPERIMENTAL PROCEDURES
Growth conditions, DNA preparation and cloning -Bacillus halodurans DSM497 (DSMZ stock, Braunschweig, Germany) was routinely cultured in LB medium containing 0.1 mM sodium sesquicarbonate (4.2 g NaHCO 3 , 5.3 g Na 2 CO 3 per Liter) at pH 9.7 ("LB-ha broth") at 37 °C. DNA was prepared from late-log phase cultures by the following procedure: After washing cells twice with TE buffer (10 mM Tris-HCl, pH 8.0; 1 mM Na-EDTA), 0.1 mM lysozyme was added and the solution was incubated for 10 min at 37 °C. Upon addition of 2% (w/v) SDS and 1 M sodium perchlorate, cell proteins were precipitated, and after extraction with chloroform/isoamyl alcohol at 24:1 v/v DNA was separated into the aqueous phase. DNA was precipitated by addition of 2 vol. ethanol, washed in 70 % (v/v) ethanol, dried under vacuum and dissolved in TE buffer. RNA was removed by RNase I treatment (0.1 mg/ml) for 1 h at 37 °C. For amplification of genes BH1040 and BH1037, primer pairs ATATCTAGATAACGAGGGCAAAAA ATGATCGAGCCACCTGTTATGAATG (BH1040_forward)/ GCTCGGTTTGCGAGGGCACGTCC (BH1040_reverse) and ATAGGATCCGGAGGAAATGAACCA AGCGAAG (BH1037_forward)/ ATAAAGCTTCTATTGTGTAAGGGAA TCAACGAG (BH1037_reverse) were used, respectively, according to the database genome sequence of B. halodurans C-125 (restriction sites are underlined, primer BH1040_reverse blunt end and phosphorylated). BH1040 and BH1037 were cloned into pMM30 and pCB28a+ (12) resulting in pMM30-1 and pMM20 expression vectors providing a Cterminal Strep-tag II and an N-terminal His 6 -tag, respectively. In vitro DNA manipulations and E. coli transformation were done according to described methods (27) . Recombinant protein production and purification -E. coli BL21 cells transformed with the desired expression vector were grown in LB medium at 37 °C until OD 600 of 0.5 and then induced with 0.2 mg/L anhydrotetracycline (pMM30-1) or 0.2 mM isopropyl-β-Dthiogalactopyranoside (pMM20) for 3 h at 30 °C. For purification of recombinant B. halodurans BH1040, cells were harvested, resuspended in 150 mM NaCl, 100 mM Tris-HCl, pH 8.0 disrupted by using a French press (Thermo Scientific), and the filtrated lysate was subjected to StrepTactin chromatography using an FPLC purifier system (Pharmacia) and a column with 2 ml Strep-Tactin Superflow material (IBA). The recombinant protein was eluted with 2.5 mM D-desthiobiotin (IBA). Purification of recombinant B. halodurans BH1037 and recombinant B. subtilis SufU was done by Ni 2+ -NTA chromatography as described (12, 35) . The pooled and concentrated elution fractions were then applied to size exclusion chromatography using a 26/60 superdex 200 column and 150 mM NaCl, 100 mM Tris-HCl, pH 8.0. Fractions of the dominant single UV-peak were analyzed by SDS-PAGE and those containing pure protein concentrated using centrifugal filter devices with a 10,000 cutoff.
Protein concentration was determined by Bradford method (28) using a BSA calibration curve. Protein was shock frozen in liquid nitrogen and stored at -80 °C. UV-vis analysis -For measurement of oxidized protein spectra, purified protein was diluted to desired concentration in 150 mM NaCl, 100 mM Tris-HCl, pH 8.0 and the solution was placed into a quartz cuvette (n = 1 cm). For measurement of reduced protein spectra, the protein was treated with 5 mM sodium dithionite under anaerobic conditions (95% N 2 / 5% H 2 ). Reduced protein was placed into an anaerobic cuvette, which was tightly sealed before measurements were performed. Spectra were recorded at an Ultrospec 3000 spectrophotometer usually from 250-800 nm. Data were analyzed with SWIFT Scan 2.06. Analytical gel filtration -A Zorbax GF-250 column was equilibrated with 150 mM NaCl, 100 mM Tris-HCl, pH 8.0, using an Agilent HPLC system (1200 series). The column was calibrated using a mixture of Ferritin (440 kDa), Aldolase (158 kDa), Conalbumin (75 kDa), Ovalbumin (44 kDa), Carbonic Anhydrase (29 kDa), and Aprotinin (6.5 kDa) at 0.5 ml/min at 25°C. Then, 100 µg purified recombinant FchR was applied at the same flow rate and temperature. UV spectra at 280 nm were recorded and analyzed with Agilent ChemStation software B.03. Western analysis -B. halodurans wildtype (WT) and B. halodurans ΔfchR were cultivated in LB-ha broth supplemented with 100 µM FeCl 3 or different concentrations (5-50 µM) of 2,2"-bipyridyl (BP) and 1,10-phenanthroline (Phen). Cells were harvested at late log-phase, washed twice with TE buffer, and were disrupted after addition of 1 mM serine protease inhibitor PMSF by sonication (4 x 1 min at 50 W). Cell debris was removed by centrifugation (15,000 x g, 60 min, 4°C), and clear lysate was separated. Protein concentrations of cytosolic extracts were determined by Bradford method, and 20 µg were applied to each lane for SDS-PAGE (12% acryl amide). Further, debris fractions containing major portions of cell membranes were resolubilized in 8 M urea, 0.5 M DTT by boiling at 95 °C for 20 min. Resolubilized membrane fractions were also subjected to SDS-PAGE. As control, 0.1 µg purified recombinant FchR was additionally loaded on the gels, which were developed for 1.2 h at 150 mV, and then proteins were blotted onto a hyperbond PVDF membrane for 1 h at 200 mV. After blocking with 2.5% (w/v) BSA in TBS, polyclonal FchR-specific antibody (Pineda, Berlin, Germany) was applied for 12 h, and after washing secondary antibody (goat anti-rabbit IgG coupled with alkaline phosphatase; Bio-Rad) was applied for 2 h. Blots were developed using BCIP and NBT at pH 9.5 for signal detection. EPR redox titration -20 µM holo-FchR in 10 mM Tris-HCl, pH 7.5, 50 mM NaCl were anaerobically incubated and mixed with redox mediators methyl viologen, benzyl viologen, neutral red, safranine T, phenosafranine and anthraquinone-2-sulfonate (40 μM each). Actual redox potentials were determined continously by using a platinum electrode and a Ag/AgCl reference electrode under constant mixing of the protein-indicator solution as previously described (29) . Increasing amounts of dithionite were added stepwise, and 13 samples were taken between -215 mV/NHE (corresponding to the start potential) and -520 mV/NHE (corresponding to complete reduction). Immediately frozen samples were measured at 77 K, and both amplitudes and slopes of the g y = 1.956 feature were plotted after corrections for sample volumes and concentrations and analyzed by fitting to the Nernst equation. HPLC and mass spectrometric analysisCulture supernatant extracts were analyzed by using a C-18 column (Macherey-Nagel) with a water/0.05% formic acid (A) and acetonitrile/0.045% formic acid (B) gradient from 5% to 95% B in 30 min with column temperature of 45 °C. ESI mass spectra of the eluting compounds were recorded in positive ion mode within the mass range of 100 -1000 m/z. For a complete desalting of proteins by HPLC using an Agilent 1100 system, samples were applied to a monolithic 50/1 ProSwift RP-4H column (Dionex). Desalted proteins were eluted by the following gradient of A and B at a column temperature of 40 °C and a flow rate of 0.2 ml/min: Isocratic elution with 5% A for two minutes, followed by a linear gradient to 95% B within 8 8 .0 was adjusted to the desired concentration, and 2 ml were applied into a 1 x 1 cm 2 quartz cuvette. The cuvette was placed into an FP-6500 spectrofluorimeter (Jasco) and thermostatted at 22 °C. Concentrated ferric siderophore stock solutions were freshly prepared and added stepwise to the protein solution.
Chemical iron and sulfide determination -
Tyrosine/Tryptophan fluorescence was measured after excitation at 280 nm (slit width 5 nm) at 340 nm (slit width 5 nm). Each measurement was averaged three times. Data analysis and K D calculation were done as described previously (30 .0, 9.5 (although pH 9.5 is at the limit of the optimal buffer range, the same buffer was used to assure comparable experimental conditions). Fe/S cluster spectra were measured before and after incubation to monitor cluster reoxidation. To test efficiency of FchR reduction by a physiological electron donor, measurements were repeated by using 2 mM NADH, NADPH, FADH 2 (all obtained from Sigma) and ferredoxin (Fd; source: S. oleracea; Sigma), which was reduced with dithionite and purified anaerobically. Detailed kinetics were then performed in 50 mM Tris-HCl, pH 8.0, 100 mM NaCl at 25 °C by using 1 µM holo-FchR and 10 µM Fd together with a regenerative system consisting of NADPH:Fd oxidoreductase (source: S. oleracea; Sigma) which bears a lowpotential flavin with E 1/2 = -442 mV at pH 8.0 (32) and reversibly transfers electrons to Fd, possessing a low-potential Fe 2 S 2 cluster with E 1/2 = -420 mV (33) , through formation of a 1:1 stoichiometric complex (32) . Further, Glucose-6-phosphate dehydrogenase (source: S. cerevisiae; Sigma) was used to ensure low steady-state concentrations of NADP + potentially acting as a competitive inhibitor of NADPH:Fd oxidoreductase (34). Nonlimiting rate determination was done with starting concentrations of 2 mM glucose-6-phosphate and 2 mM NADPH, 0.5 U of regenerative enzymes, and varying concentrations of potassium ferricyanide (E°[pH 7.0] = 436 mV). Conditions found to be sufficient for non-limiting electron transfer were then applied to FchRdependent kinetics with ferric siderophores over a substrate concentration range from 1 to 1000 µM. After 10 min pre-incubation of regenerative enzymes with their substrates (glucose-6-phosphate, NADPH, Fd) and FchR, ferric siderophores were added, and starting velocities of iron release were measured by 3 min of incubation (initially determined to be within the time-dependent linear catalytic range (39) (40) . Shortly, protoplasts were generated in Protoblast(PB)-buffer containing 20% (w/v) sucrose, 10 mM MgCl 2 and 20 mM Tris-HCl, pH 9.2 supplemented with 5% (w/v) lysozyme at 37 °C. They were harvested by centrifugation at 3000 x g for 10 min and resuspended in PB-buffer. DNA was added together with 25% (w/v) PEG 8000, and after 10 min incubation, two-times Penassay broth containing 20% (w/v) sucrose was added with equal volume, and protoplasts were recovered by centrifugation. Treated protoblasts were resuspended in Penassay broth-mixed PBbuffer and gently shaken for 30 min at 30 °C. Transformants were selected on modified DM3 regeneration plates with chloramphenicol at 20 µg/ml. Growth assays and siderophore tests in defined medium -For defined growth studies with B. halodurans WT and ΔfchR, modified iron-limited Belitsky minimal medium (41) at pH 9.5 was used. Strains were inoculated to a starting OD 600 of 0.05, and growth was monitored continously until stationary phase was reached. Endogenous siderophore production was tested by Arnow (42) and modified Csaky test (43) . Extraction of culture supernatants for analysis of siderophore species was done as described (44) . For siderophore supplementation assays, microtiter scale cultures were used which were supplemented with 100 µM of FeCl 3 , ferric siderophores or Ga[III]-loaded siderophores. Cultured were incubated at 300 rpm at 37 °C, and growth was monitored by using a microtiter plate reader. Three independent cultures for each condition were set up, and growth data were plotted with their corresponding standard deviations. ICP-MS analysis -Cultures were inoculated with overnight cultures to a starting OD 600 of 0.05 and were harvested after reaching stationary growth phase. Cells were centrifuged at 18,000 × g for 5 min, pellets were washed three times with buffer containing 10 mM Tris-HCl, 1 mM EDTA, pH 7.5 and finally with milliQwater to remove extracellular traces of salt. Cells were dried for 20 h at 100 °C, treated with suprapure nitric acid for quantitative breaking, and intracellular metal contents were analyzed by inductively coupled plasma mass spectrometry (ICP-MS) using an ICP-MS Agilent 7500ce. Three biological replicates for each condition were analyzed, and averaged data of the measurements were given with corresponding standard deviations. Analysis of metal contents in protein solutions (20 mM Tris-HCl, pH 7.5) was done after 1:20 dilution appropriate to obtain the required sample volumes and identical sample viscosities. Yttrium was added to all samples as an internal standard.
RESULTS

Identification of iron-associated reductase genes in
Firmicutes -Several species within the Firmicutes group possess putative non-flavin reductase genes with conserved C-terminal cysteines that are closely associated with ABC-type iron uptake systems ( Fig.  1A-B) . A phylogenetic analysis shows that these Firmicutes reductases form a rather heterogenous, but distinct cluster clearly distinguished from the homogenous cluster of enterobacterial FhuF-like reductases which show a high degree of conservation among each other (Fig.  1C ). Transmembrane-spanning segments predicted within the FhuF sequences are not or with high uncertainty predicted within the Firmicutes reductase sequences, suggesting furthermore topological differences between these reductases of different phyla. Within the Bacillus genus, the conserved C-terminal CC-x 4 -C-x 6 -Cx 2 -C motif within the reductase sequences partially differs from the CC-x 10 -C-x 2 -C FhuF motif, and the identities of the full length amino acid sequences compared to E. coli FhuF are between 4-14%, indicating that the homology of the corresponding genes is uncertain. This suggests that the predicted Firmicutes reductases represent a novel type of putative FSRs with C-terminal conserved cysteine motifs, and suggest to show potentially novel features compared to FhuF. Among known Bacillus species, B. halodurans is one exception since it lacks genes to synthesize or utilize catecholate siderophores. Although rather closely related to the non-alkaliphilic model bacterium B. subtilis (45) , the complete bacillibactin pathway is absent in the genome including biosynthesis genes dhbACEBF, ferric bacillibactin uptake genes feuABC and trilactone hydrolase besA. However, uptake systems for elemental iron, iron dicitrate and iron hydroxamates are present and similar to the corresponding systems in B. subtilis. To test siderophore production in B. halodurans, iron-limited minimal medium cultures were grown until stationary phase, and secretion of catecholate and/or hydroxamate compounds was tested by using the Arnow and Csaky tests, respectively. Only the Csaky test specific for hydroxamates gave a positive response (data not shown), revealing the ability of B. halodurans to produce hydroxamic compounds during iron limitation, which is in agreement with a recent study (46) . HPLC-MS analysis of extracted irondeprived cultures revealed the presence of a mass pattern according to schizokinen (Fig. 1D) (47) . This citrate-hydroxamate siderophore, which is structurally closely related to aerobactin produced by Enterobacteriaceae, was so far only isolated from Bacillus megaterium (48) (49) . However, the present genome analysis revealed in both B. megaterium and B. halodurans the same gene cluster with high homology that comprises all genes found to be involved in rhizobactin 1021 biosynthesis in Sinorhizobium meliloti except rhbG, which is there required for asymmetric acylation of the otherwise schizokinen-like scaffold (Fig. 1D) Production and initial characterization of the BH1040 gene product -To address the function of BH1040, the gene was recombinantly expressed as a Strep-tag II fusion and the protein purified via Streptactin chromatography. The reddishbrown color of concentrated elution fractions pointed to the binding of a chromogenic cofactor. The UV-vis spectrum of the aerobically purified protein showed in addition to 280 nm significant absorption features at 330 nm and 450 nm as well as slight additional peaks at 560 nm and 670 nm, which were strongly weakened upon dithionite reduction, indicating the binding of an Fe/S cluster ( Fig. 2A) .
+ cluster was found with g values g z = 2.001, g y = 1.956, g x = 1.866 (Fig. 3A) . These values are similar to those reported for FhuF (25) , but the total FchR EPR spectrum is broader, and thus g z and g x are ranged above and below the corresponding FhuF g values, respectively. By using a 1 M Cu[II]-EDTA standard, the cluster-binding holo-protein fraction was estimated with 25 µM in a total protein concentration of 55 µM. Thus, about half of the fraction of the recombinantly purified protein was found to be loaded with the Fe/S cofactor. These findings were supported by mass spectrometric analysis revealing the presence of two fractional species at nearly equal ratios (Fig 2B) . One species showed the mass expected for the recombinant apo-protein, while the other species showed a mass shift of plus 174 corresponding to the presence of a [2Fe-2S] cluster. This indicates that one BH1040 monomer is able to bind one complete Fe/S cofactor. Chemical determination of releasable iron and sulfide revealed equal molar ratios of both compounds, which were further found to be in molar stoichiometries of 1:1 with total purified protein. Given a holo-protein fraction of nearly 50%, this indicated the binding of two labile iron and sulfur species per holo-protein monomer. The same molar ratio of iron to holo-protein content was obtained by ICP-MS analysis of an BH1040 dilution series over a range of 10 0 to 10 5 ppb. To further determine a possible oligomerization state of the protein, analytical gel filtration was performed, revealing that the protein dominantly exists in the monomeric state (Fig. 2C) . (Fig. 2D) . As a result, the protein was detected in cytosolic fractions of cultures treated with each 5 µM or 50 µM of both 2,2"-bipyridyl and 1,10-phenanthroline demonstrating its iron-dependent induction. No signal was detected in membrane fractions even in presence of each 75 µM 2,2"-bipyridyl and 1,10-phenanthroline, suggesting that BH1040 is a cytosolic protein and not associated with the cytosolic membrane. Determination of the [2Fe-2S] cluster redox potential -To determine the Fe/S cluster midpoint redox potential as an estimate of the redox capacity of holo-BH1040, the protein was subjected to anaerobic EPR titration using dithionite as the reducing agent. First, it was tested if the Fe/S cluster was stable against elongated incubation with dithionite. EPR analysis revealed complete stability of the [2Fe-2S] + signal over 45 min of continuous dithionite reduction at pH 7.5 and thus, redox titration was performed at same pH within this time frame. By following the amplitude changes of the g y = 1.956 feature, a midpoint potential of -348.4 mV (vs normal hydrogen electrode [NHE]) was determined by Nernst fitting (Fig. 3B) .
by guest on November 7, 2017 http://www.jbc.org/ Downloaded from EPR slopes were further evaluted, resulting in essentially the same potential. Thus, FchR revealed to possess a midpoint potential lower than free flavin or nicotinamide cofactors and even lower than determined for the E. coli FhuF reductase (26) . Characterization of the substrate spectra of BH1040 and BH1037 -To issue the capacity of BH1040 to release iron from ferric siderophores, the protein was reduced with 5 mM dithionite under anaerobic conditions. Dithionite was removed by size exclusion chromatography, and reduction of the [2Fe-2S] cluster was proofed by UV-vis spectroscopy. The reduced holo-protein was then incubated with several ferric siderophores for 10 min at pH 8.0, and both the UV-vis spectrum of the Fe/S cofactor and the amount of released Fe [II] were analyzed. In case of Fe[III]-dicitrate and several ferric hydroxamates, the UVvis spectrum of the cluster was found to shift into the oxidized state, but not in case of ferric triscatecholates (Fig. 4A) (Fig. 4C) . The high-rate electron transfer was then applied to perform FchRdependent kinetics with various potential ferric siderophore substrates. All kinetics followed a Michaelis-Menten-type behaviour (Fig. 4D) (Fig. 6A) . Thus, the determined binding affinities for these substrates were found to be in a similar range within the same order of magnitude. This suggests that a common motif of these complexes is responsible for ligand-protein interaction. Since no binding of non-loaded siderophores was observed, formation of the octahedral iron-oxo motif seems to be essential for the substrate-dependent interactions. In addition to the determination of enzyme-ligand binding affinities, the possibility of Fe/S cluster rearrangement upon substrate binding was tested, which may occur upon occupation of the inner coordination sphere of the metal-oxo center during electron transfer. (Fig. 6B) , showing that the catalytic properties of FchR remained fully intact. Thus, since cluster geometry was not found to be affected in presence of both redox-inert and redox-active metal-oxo centers, we infer no direct interaction between Fe/S cofactor and siderophore substrate. Growth analysis of an fchR deletion mutant -In order to test the in vivo effect of FchR deficiency, a B. halodurans fchR deletion mutant was constructed by replacing the gene via homologous recombination by a chloramphenicol resistance cassette upon protoplast transformation. The obtained mutant strain was subjected to growth studies in defined minimal medium. Cell density of ΔfchR under iron limited conditions after entry into stationary phase was about 25% of wild-type (WT) culture. However, addition of 100 µM Fe[III] restored growth to about 87% compared with WT under iron repletion (Fig. 7A) 
ICP-MS analysis reveals that the fchR mutant accumulates iron intracellularly -
Since the fchR mutant showed a strongly reduced growth during iron deprivation, we analyzed the metal content of the intracellular fractions of WT and mutant cells by using ICP-MS (Table 2) . Strikingly, the fchR mutant was found to contain a 4.4-fold higher intracellular iron content than the WT. Under iron repletion (100 µM FeCl 3 ), the relative cytosolic iron level in ΔfchR shifted to 1.2-fold compared to the WT and, thus, was still higher even under conditions of extracellular iron excess. While addition of 1 mM citrate to iron-repleted cultures during mid-log growth phase still increased WT growth compared with iron-repleted cultures not supplemented with citrate, growth of mutant cultures treated in the same way was not significantly affected, but intracellular iron content further increased 4.5-fold. To address if intracellular accumulations of iron in the fchR mutant was dependent on the presence of ferric siderophore species, iron-limited cultures of WT and ΔfchR supplemented with 100 µM Fe[III]-dicitrate, Fe[III]-aerobactin, ferrichrome and ferrioxamine E (see Fig.  7A ) were subjected to total cellular iron determination. While supplementation of ferric siderophores led to intracellular increase of iron content in the WT in the range of 2.5-7.5-fold, the increase was drastically higher in the mutant ranging from about 4.0-13.0-fold compared with non-supplemented cultures. In contrast, supplementation with Ga[III]-charged siderophores (see Fig. 7B ) led to a comparable accumulation of gallium in both mutant and WT, although at a lower level compared to the iron accumulation ( 
DISCUSSION
In this study, we present the first combined kinetic, inhibitory and mechanistic analysis of a non-flavin-dependent FSR within bacterial systems. We discovered a pattern of association between ferric siderophore uptake systems and putative reductases with C-terminal Fe/S cluster-binding motif in several species of the Firmicutes group, in which the presence of substrate-specific FSRs was not shown before. One of these reductases, FchR, was characterized in B. halodurans and found to possess similar and distinct features to the E. coli FhuF reductase. While utilization of an Fe/S cofactor and a substrate spectrum that includes hydroxamate siderophores was also described for FhuF, the differences to the FhuF-type reductases are significant: FchR was found to be a cytosolic enzyme and was not localized in cytoplasmic membrane fractions in contrast to E. coli FhuF (25) (26) . The primary function of FhuF was found to be associated with ferric hydroxamate reduction, especially of coprogen, ferrichrome and ferrioxamine B (26) . In contrast, FchR covers a broader range of ferric siderophores including citrate-hydroxamates and carboxylates. Further, an fchR mutant was found to be growth limited during iron deprivation even in presence of different ferric siderophores, while a fhuF mutant was only found to be affected during growth with ferrioxamine B as sole iron source (57) (58) . In both fhuF mutant (26) and fchR mutant, intracellular accumulation of iron in presence of different ferric siderophores indicate that these reductases are key enzymes for further cytosolic metabolization of these iron sources. However, different routes of iron release via the hydrolytic triscatecholate-trilactone pathway or the reductive hydroxamate pathways may form bypasses for each other in E. coli, while B. halodurans obviously lacks hydrolytic release pathways and hence fchR seems to be a general bottleneck for siderophoredependent iron release processes. The close association of fchR with a ferric citrate-hydroxamate uptake system further differentiates it from lone-standing fhuftype reductases in Enterobacteriacaea, and points to its coordinated expression during iron limitation together with ferric substrate uptake genes. Interestingly, the substrate spectrum of FchR includes both carboxylate-and (citrate)-hydroxamatetype siderophores, and there was a clear relationship between redox potential of the enzyme Fe/S cofactor and the reductive potential of the ferric substrate. Thus, although translationally coupled with a ferric citrate-hydroxamate uptake system specific for Fe[III]-schizokinen and Fe[III]-aerobactin, the catalytic efficiency for Fe[III]-dicitrate reduction was higher than for ferric citrate hydroxamates. This suggests the possibility of effective substrate competition dependent on the available iron source under native conditions. While utilization of citrate as an iron source is a rather ubiquitous feature due to its general presence in primary metabolism, the utilization and availibility of secondary metabolite siderophores varies among habitats. Thus, in a species that primarily uses ferric siderophore reduction for iron assimilation in an alkaline environment that renders citrate into a higher-affinity siderophore than under neutral or acidic conditions, higher efficiency for Fe[III]-dicitrate conversion (in addition to its still favorable redox potential for fast iron release) may have been forced evolutionary. The production of schizokinen as a citratehydroxamate-type siderophore in B. halodurans is first shown in this study, and the putative schizokinen biosynthesis gene cluster that additionally contains a predicted major facilitator superfamily (MFS)-type efflux transporter was identified as well. Together with the substrate specificity of FchR and the uptake-associated binding protein BH1037, a complete siderophore pathway for endogenous schizokinen utilization can now be suggested, which in B. halodurans includes seven genes (BH2618 -BH2624) for biosynthesis and efflux and four genes (BH1037 -BH1040) for uptake and cytosolic iron release (Fig. 1B,D) . The observed binding of different ferric substrates with moderate to low affinities by FchR indicates a general relaxed recognition of ferric siderophore complexes leading to promiscuity within the tested substrate spectrum. In contrast, binding of the apo-forms of these siderophores was not observed, indicating that the formation of the iron-oxo centers in the siderophore complexes were crucial for establishing protein interaction. Although structural information is not present for FchR-type reductases, ferric siderophore binding via the oxygen donor atoms involved in ferric iron coordination is a common theme in bacterial ferric siderophore binding and receptor proteins (59) (60) (61) (62) (63) (64) , and the iron-oxo-dependent substrate recognition mode of FchR suggests that binding of this structural motif is essential during catalysis. Further, K m values were found to correspond to K D values of protein-substrate interaction especially for substrates that have lower turnover rates. These low-potential substrates show saturation of catalysis at low concentrations, likely due to longer interaction between substrate and protein according to enzyme cofactor-limited electron transfer rates. This further indicates that first order rate constant k 2 is generally much lower than k -1 and further decreases with the drop of substrate redox potential, again pointing to the interdependence of cofactor redox potential and substrate binding affinity during the reductive process. This leads to the definition of two different kinetic modes established for substrates over a wide range of the redox potential scale: high K m and k cat for high redox potential substrates like Fe[III]-dicitrate, low K m and k cat for low-potential substrates within the group of hydroxamates. The latter mode is possibly achieved by efficient binding at the ferric-oxo center until electron transfer is completed and fast product dissociation occured. The mechanism of increasing binding affinities towards lower potential substrates likely explains the capability of electron transfer to those substrates ranging outside the effective Fe/S cluster redox potential such as ferrioxamine E which is about 70 mV below the determined midpoint range of -348 ± 59 mV. However, strong limitations of transfer apparently occur if substrate redox potentials range far below as in case of ferric triscatecholates, which were not observed to saturate catalysis at high concentrations and which showed marginal turnover rates. Further, the mechanism of electron transfer seems not to involve a ternary complex formation between Fe/S cofactor, siderophore metal center and siderophore donor atoms. Either the resulting species is kinetically too instable that it cannot be trapped by redox-inert metal centers or, more likely, charge transfer does not proceed directly via cofactor interaction with the siderophore metal center. This unlikely inner-sphere electron transfer has been reported so far only for metal chelate reduction by small reducing molecules or free metal ions (7) . Still, an inner-sphere electron transfer via a catalytically active residue that transiently occupies the substrate metal coordination sphere cannot be excluded. However, since kinetic exchange rates between ferric ions and their siderophore ligands are generally rather low (65) , electron transfer via an outer-sphere mechanism is more likely in terms of fast reaction kinetics and could involve the intrinsic ligand-to-metal charge-transfer which is mediated by the ligand donor atoms. Despite the capability of reducing substrates including low-potential ferric hydroxamates, the strong enhancement of catalytic rates in the presence of an Fe [II] acceptor during the reaction suggests that iron release can be a rate limiting step during iron assimilation if ferrous iron scavengers are either saturated or, on the other hand, not present in sufficient amount. However, as shown previously, induction of iron-cofactor binding proteins such as B. subtilis or E. coli suf genes (66-67) occurs during iron-limiting conditions, which could contribute to an increase of iron release rates by cytosolic iron sequestration. Thus, the enhancement of ferrous iron release observed in the presence of apo-SufU, which was most likely due to equilibrium displacements between free substrate (Fe[III]·L) and product (Fe[II]·L) concentrations points to a possibility of shifting redox potentials in the cytosol as predicted previously (18) . Thus, the mechanism of released iron scavenging by efficient intracellular sinks such as Fe/S cluster or heme assembly systems can be seen as a further mode of increasing the actual redox potentials of the FSR substrates. Since these intracellular systems are ubiquitous, this strategy can be referred to as a rather general one in addition to compartmentspecific mechanisms of low-potential increase like extracellular or periplasmic acidification, or intracellular drain of iron during extracellular release that is coupled with efficient uptake such as in the yeast FRE/FTR1-FET3 system (15 (Fig. 8) 
